A decrease in EAAT2 levels in the astrocytes of the sclerotic hippocampus has been found in several studies based on clinical and postmortem data in people with temporal lobe epilepsy [67,68], but conflicting data were obtained in animal epilepsy models. This evidence concerns the gene SLC1A2 and epilepsy.